Sera Prognostics Inc. (SERA) NASDAQ
$8.38 (0.05) (-0.59%)
Market Cap: $267.11M
As of 05/16/24 03:59 PM EDT. Market closed.
Sera Prognostics Inc. (SERA)
NASDAQ
$8.38
(0.05) (-0.59%)
Market Cap: $267.11M
As of 05/16/24 03:59 PM EDT. Market closed.
Add to Portfolio
sera prognostics is a private biotechnology company developing innovative diagnostic tests designed for the early prediction of preterm birth risk and other pregnancy complications. sera’s tests are designed to help better inform the care of a mother and her unborn child during pregnancy, and potentially lead to improved health. the company has assembled a strong management team and board of ... read more
COMPANY PROFILE
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Full Time Employees
96
URL
Address
.
PRICE CHART FOR SERA PROGNOSTICS INC
From:
To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$8.28
Previous Close
$8.43
Days Range
$8.12 - $8.65
52 week range
$1.52 - $12.36
Volume
135,899
Avg. Volume (30 days)
120,410
Market Cap
$267.11M
Dividend Yield
-
P/E
(7.91)
Shares Outstanding
31,686,018
Open
$8.28
Previous Close
$8.43
Days Range
$8.12 - $8.65
52 week range
$1.52 - $12.36
Volume
135,899
Avg. Volume (30 days)
120,410
Market Cap
$267.11M
Dividend Yield
-
P/E
(7.91)
Shares Outstanding
31,686,018
FINANCIAL STATEMENTS FOR SERA PROGNOSTICS INC
LOADING...
Open in: 
Open in:
INSIDER TRANSACTIONS FOR SERA PROGNOSTICS INC
| Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
| Kearney Paul | Chief Data Officer | May 15, 2024 | Sale | $8.24 | 10,387 | 85,589 | 185,300 | May 15, 2024, 06:23 PM |
| Kearney Paul | Chief Data Officer | May 08, 2024 | Sale | $9.59 | 4,205 | 40,326 | 154,833 | May 10, 2024, 05:42 PM |
| Boniface John J. | Chief Scientific Officer | May 08, 2024 | Sale | $9.59 | 4,902 | 47,010 | 134,869 | May 10, 2024, 05:41 PM |
| Jackson Benjamin | General Counsel | May 08, 2024 | Sale | $9.59 | 4,902 | 47,010 | 145,277 | May 10, 2024, 05:41 PM |
| Aerts Austin | Chief Financial Officer | May 08, 2024 | Sale | $9.59 | 6,592 | 63,217 | 315,896 | May 10, 2024, 05:41 PM |
| Lindgardt Zhenya | Chief Executive Officer | May 08, 2024 | Sale | $9.59 | 11,992 | 115,003 | 896,112 | May 10, 2024, 05:41 PM |
| Harrison Robert Gardner | Chief Information Officer | May 08, 2024 | Sale | $9.59 | 4,902 | 47,010 | 140,795 | May 10, 2024, 05:40 PM |
| Boniface John J. | Chief Scientific Officer | Mar 28, 2024 | Option Exercise | $0.91 | 24,474 | 22,271 | 164,245 | Mar 28, 2024, 05:56 PM |
| Boniface John J. | Chief Scientific Officer | Mar 27, 2024 | Option Exercise | $0.91 | 48,909 | 44,507 | 188,680 | Mar 28, 2024, 05:56 PM |
| Boniface John J. | Chief Scientific Officer | Mar 28, 2024 | Sale | $9.04 | 24,474 | 221,245 | 139,771 | Mar 28, 2024, 05:56 PM |
| Boniface John J. | Chief Scientific Officer | Mar 27, 2024 | Sale | $9.62 | 52,662 | 506,608 | 139,771 | Mar 28, 2024, 05:56 PM |
| Lindgardt Zhenya | Chief Executive Officer | Mar 26, 2024 | Sale | $9.37 | 38,899 | 364,484 | 908,104 | Mar 26, 2024, 08:00 PM |
| Aerts Austin | Chief Financial Officer | Mar 26, 2024 | Sale | $9.37 | 8,092 | 75,822 | 322,488 | Mar 26, 2024, 08:00 PM |
| Boniface John J. | Chief Scientific Officer | Mar 26, 2024 | Sale | $9.55 | 21,438 | 204,733 | 143,524 | Mar 26, 2024, 05:38 PM |
| Boniface John J. | Chief Scientific Officer | Mar 25, 2024 | Sale | $9.10 | 22,163 | 201,683 | 164,962 | Mar 26, 2024, 04:20 PM |
| Boniface John J. | Chief Scientific Officer | Mar 06, 2024 | Sale | $9.02 | 1,664 | 15,009 | 187,125 | Mar 07, 2024, 04:16 PM |
| Aerts Austin | Chief Financial Officer | Mar 06, 2024 | Sale | $9.02 | 444 | 4,005 | 330,580 | Mar 07, 2024, 04:16 PM |
| Kearney Paul | Chief Data Officer | Mar 06, 2024 | Sale | $9.02 | 1,028 | 9,273 | 159,038 | Mar 07, 2024, 04:16 PM |
| Harrison Robert Gardner | Chief Information Officer | Mar 06, 2024 | Sale | $9.02 | 2,138 | 19,285 | 145,697 | Mar 07, 2024, 04:15 PM |
| Jackson Benjamin | General Counsel | Mar 06, 2024 | Sale | $9.02 | 1,856 | 16,741 | 150,179 | Mar 07, 2024, 04:15 PM |
| Jackson Benjamin | General Counsel | Feb 06, 2024 | Sale | $8.03 | 5,665 | 45,490 | 152,035 | Feb 07, 2024, 04:57 PM |
| Boniface John J. | Chief Scientific Officer | Feb 06, 2024 | Sale | $8.03 | 5,665 | 45,490 | 188,789 | Feb 07, 2024, 04:57 PM |
| Kearney Paul | Chief Data Officer | Feb 06, 2024 | Sale | $8.03 | 4,984 | 40,022 | 160,066 | Feb 07, 2024, 04:56 PM |
| Harrison Robert Gardner | Chief Information Officer | Feb 06, 2024 | Sale | $8.03 | 5,665 | 45,490 | 147,835 | Feb 07, 2024, 04:56 PM |
| Lindgardt Zhenya | Chief Executive Officer | Feb 06, 2024 | Sale | $8.03 | 27,997 | 224,816 | 947,003 | Feb 07, 2024, 04:56 PM |
| Aerts Austin | Chief Financial Officer | Feb 06, 2024 | Sale | $8.03 | 9,786 | 78,582 | 331,024 | Feb 07, 2024, 04:56 PM |
| Jackson Benjamin | General Counsel | Dec 07, 2023 | Sale | $5.22 | 10,000 | 52,200 | 157,700 | Dec 07, 2023, 09:35 PM |
| Boniface John J. | Chief Scientific Officer | Dec 07, 2023 | Sale | $4.80 | 5,000 | 24,000 | 194,454 | Dec 07, 2023, 09:35 PM |
| Harrison Robert Gardner | Chief Information Officer | Jun 05, 2023 | Sale | $3.23 | 5,000 | 16,150 | 28,500 | Jun 06, 2023, 04:07 PM |
| Kearney Paul | Chief Data Officer | Apr 06, 2023 | Option Exercise | $0.75 | 24,050 | 18,038 | 40,050 | Apr 07, 2023, 04:14 PM |
| Boniface John J. | Chief Scientific Officer | Sep 08, 2022 | Option Exercise | $0.73 | 844 | 616 | 47,354 | Sep 09, 2022, 04:17 PM |
| Boniface John J. | Chief Scientific Officer | Jul 27, 2022 | Option Exercise | $0.73 | 1,000 | 730 | 47,510 | Jul 27, 2022, 06:54 PM |
| Boniface John J. | Chief Scientific Officer | Jul 26, 2022 | Sale | $2.15 | 2,725 | 5,859 | 46,510 | Jul 27, 2022, 06:54 PM |
| Boniface John J. | Chief Scientific Officer | Jul 27, 2022 | Sale | $2.22 | 1,000 | 2,220 | 46,510 | Jul 27, 2022, 06:54 PM |
| Boniface John J. | Chief Scientific Officer | Jul 19, 2022 | Sale | $1.86 | 2,725 | 5,069 | 49,235 | Jul 19, 2022, 07:38 PM |
| Boniface John J. | Chief Scientific Officer | Jul 12, 2022 | Sale | $1.84 | 2,725 | 5,014 | 51,960 | Jul 13, 2022, 04:06 PM |
| Boniface John J. | Chief Scientific Officer | Jul 05, 2022 | Sale | $1.63 | 2,725 | 4,442 | 54,685 | Jul 05, 2022, 06:37 PM |
| Boniface John J. | Chief Scientific Officer | Jun 29, 2022 | Option Exercise | $0.73 | 1,000 | 730 | 58,410 | Jun 29, 2022, 07:00 PM |
| Boniface John J. | Chief Scientific Officer | Jun 28, 2022 | Sale | $1.89 | 2,725 | 5,150 | 57,410 | Jun 29, 2022, 07:00 PM |
| Boniface John J. | Chief Scientific Officer | Jun 29, 2022 | Sale | $1.72 | 1,000 | 1,720 | 57,410 | Jun 29, 2022, 07:00 PM |
| Boniface John J. | Chief Scientific Officer | Jun 21, 2022 | Sale | $1.31 | 2,725 | 3,570 | 60,135 | Jun 21, 2022, 05:34 PM |
| Jackson Benjamin | General Counsel | Jun 14, 2022 | Buy | $1.20 | 8,000 | 9,600 | 8,000 | Jun 16, 2022, 04:19 PM |
| Boniface John J. | Chief Scientific Officer | Jun 14, 2022 | Sale | $1.21 | 2,725 | 3,297 | 62,860 | Jun 16, 2022, 04:19 PM |
| Boniface John J. | Chief Scientific Officer | Jun 07, 2022 | Sale | $1.30 | 2,725 | 3,542 | 65,585 | Jun 07, 2022, 05:30 PM |
| Boniface John J. | Chief Scientific Officer | Jun 01, 2022 | Option Exercise | $0.73 | 1,000 | 730 | 69,310 | Jun 01, 2022, 05:41 PM |
| Boniface John J. | Chief Scientific Officer | Jun 01, 2022 | Sale | $1.36 | 1,000 | 1,360 | 68,310 | Jun 01, 2022, 05:41 PM |
| Boniface John J. | Chief Scientific Officer | May 31, 2022 | Sale | $1.45 | 2,725 | 3,951 | 68,310 | Jun 01, 2022, 05:41 PM |
| Boniface John J. | Chief Scientific Officer | May 24, 2022 | Sale | $1.54 | 2,725 | 4,196 | 71,035 | May 24, 2022, 06:16 PM |
| Boniface John J. | Chief Scientific Officer | May 17, 2022 | Sale | $1.55 | 2,725 | 4,224 | 73,760 | May 17, 2022, 06:41 PM |
| Boniface John J. | Chief Scientific Officer | May 10, 2022 | Sale | $1.97 | 2,725 | 5,368 | 76,485 | May 10, 2022, 06:47 PM |
| Boniface John J. | Chief Scientific Officer | May 04, 2022 | Option Exercise | $0.73 | 1,000 | 730 | 80,210 | May 04, 2022, 06:15 PM |
| Boniface John J. | Chief Scientific Officer | May 04, 2022 | Sale | $2.17 | 1,000 | 2,170 | 79,210 | May 04, 2022, 06:15 PM |
| Boniface John J. | Chief Scientific Officer | May 03, 2022 | Sale | $2.17 | 2,725 | 5,913 | 79,210 | May 03, 2022, 05:43 PM |
| Boniface John J. | Chief Scientific Officer | Apr 26, 2022 | Sale | $2.17 | 2,725 | 5,913 | 81,935 | Apr 26, 2022, 06:28 PM |
| Boniface John J. | Chief Scientific Officer | Apr 19, 2022 | Sale | $2.08 | 2,725 | 5,668 | 84,660 | Apr 20, 2022, 04:36 PM |
| Boniface John J. | Chief Scientific Officer | Apr 12, 2022 | Sale | $2.66 | 2,725 | 7,249 | 87,385 | Apr 13, 2022, 04:26 PM |
| Boniface John J. | Chief Scientific Officer | Apr 06, 2022 | Option Exercise | $0.73 | 1,000 | 730 | 91,110 | Apr 07, 2022, 04:09 PM |
| Boniface John J. | Chief Scientific Officer | Apr 05, 2022 | Sale | $3.35 | 2,725 | 9,129 | 90,110 | Apr 07, 2022, 04:09 PM |
| Boniface John J. | Chief Scientific Officer | Apr 06, 2022 | Sale | $3.02 | 1,000 | 3,020 | 90,110 | Apr 07, 2022, 04:09 PM |
| Boniface John J. | Chief Scientific Officer | Mar 29, 2022 | Sale | $3.73 | 2,725 | 10,164 | 92,835 | Mar 30, 2022, 04:07 PM |
| Boniface John J. | Chief Scientific Officer | Mar 22, 2022 | Sale | $3.68 | 2,725 | 10,028 | 95,560 | Mar 23, 2022, 04:11 PM |
| Boniface John J. | Chief Scientific Officer | Mar 14, 2022 | Sale | $3.94 | 2,725 | 10,737 | 98,285 | Mar 15, 2022, 05:58 PM |
| Boniface John J. | Chief Scientific Officer | Mar 11, 2022 | Option Exercise | $0.73 | 75,998 | 55,479 | 101,010 | Mar 14, 2022, 04:16 PM |
| Boniface John J. | Chief Scientific Officer | Dec 06, 2021 | Option Exercise | $0.73 | 25,012 | 18,259 | 25,012 | Dec 06, 2021, 09:15 PM |
Load More Insider Transactions
Buy
Sale
Option Exercise
| Owner | Relationship | Date | Value($) |
| Kearney Paul | Chief Data Officer | 05/15/2024 | 85,589 |
| Kearney Paul | Chief Data Officer | 05/08/2024 | 40,326 |
| Boniface John J. | Chief Scientific Officer | 05/08/2024 | 47,010 |
| Jackson Benjamin | General Counsel | 05/08/2024 | 47,010 |
| Aerts Austin | Chief Financial Officer | 05/08/2024 | 63,217 |
| Lindgardt Zhenya | Chief Executive Officer | 05/08/2024 | 115,003 |
| Harrison Robert Gardner | Chief Information Officer | 05/08/2024 | 47,010 |
| Boniface John J. | Chief Scientific Officer | 03/28/2024 | 22,271 |
| Boniface John J. | Chief Scientific Officer | 03/27/2024 | 44,507 |
| Boniface John J. | Chief Scientific Officer | 03/28/2024 | 221,245 |
| Boniface John J. | Chief Scientific Officer | 03/27/2024 | 506,608 |
| Lindgardt Zhenya | Chief Executive Officer | 03/26/2024 | 364,484 |
| Aerts Austin | Chief Financial Officer | 03/26/2024 | 75,822 |
| Boniface John J. | Chief Scientific Officer | 03/26/2024 | 204,733 |
| Boniface John J. | Chief Scientific Officer | 03/25/2024 | 201,683 |
| Boniface John J. | Chief Scientific Officer | 03/06/2024 | 15,009 |
| Aerts Austin | Chief Financial Officer | 03/06/2024 | 4,005 |
| Kearney Paul | Chief Data Officer | 03/06/2024 | 9,273 |
| Harrison Robert Gardner | Chief Information Officer | 03/06/2024 | 19,285 |
| Jackson Benjamin | General Counsel | 03/06/2024 | 16,741 |
| Jackson Benjamin | General Counsel | 02/06/2024 | 45,490 |
| Boniface John J. | Chief Scientific Officer | 02/06/2024 | 45,490 |
| Kearney Paul | Chief Data Officer | 02/06/2024 | 40,022 |
| Harrison Robert Gardner | Chief Information Officer | 02/06/2024 | 45,490 |
| Lindgardt Zhenya | Chief Executive Officer | 02/06/2024 | 224,816 |
| Aerts Austin | Chief Financial Officer | 02/06/2024 | 78,582 |
| Jackson Benjamin | General Counsel | 12/07/2023 | 52,200 |
| Boniface John J. | Chief Scientific Officer | 12/07/2023 | 24,000 |
| Harrison Robert Gardner | Chief Information Officer | 06/05/2023 | 16,150 |
| Kearney Paul | Chief Data Officer | 04/06/2023 | 18,038 |
| Boniface John J. | Chief Scientific Officer | 09/08/2022 | 616 |
| Boniface John J. | Chief Scientific Officer | 07/27/2022 | 730 |
| Boniface John J. | Chief Scientific Officer | 07/26/2022 | 5,859 |
| Boniface John J. | Chief Scientific Officer | 07/27/2022 | 2,220 |
| Boniface John J. | Chief Scientific Officer | 07/19/2022 | 5,069 |
| Boniface John J. | Chief Scientific Officer | 07/12/2022 | 5,014 |
| Boniface John J. | Chief Scientific Officer | 07/05/2022 | 4,442 |
| Boniface John J. | Chief Scientific Officer | 06/29/2022 | 730 |
| Boniface John J. | Chief Scientific Officer | 06/28/2022 | 5,150 |
| Boniface John J. | Chief Scientific Officer | 06/29/2022 | 1,720 |
| Boniface John J. | Chief Scientific Officer | 06/21/2022 | 3,570 |
| Jackson Benjamin | General Counsel | 06/14/2022 | 9,600 |
| Boniface John J. | Chief Scientific Officer | 06/14/2022 | 3,297 |
| Boniface John J. | Chief Scientific Officer | 06/07/2022 | 3,542 |
| Boniface John J. | Chief Scientific Officer | 06/01/2022 | 730 |
| Boniface John J. | Chief Scientific Officer | 06/01/2022 | 1,360 |
| Boniface John J. | Chief Scientific Officer | 05/31/2022 | 3,951 |
| Boniface John J. | Chief Scientific Officer | 05/24/2022 | 4,196 |
| Boniface John J. | Chief Scientific Officer | 05/17/2022 | 4,224 |
| Boniface John J. | Chief Scientific Officer | 05/10/2022 | 5,368 |
| Boniface John J. | Chief Scientific Officer | 05/04/2022 | 730 |
| Boniface John J. | Chief Scientific Officer | 05/04/2022 | 2,170 |
| Boniface John J. | Chief Scientific Officer | 05/03/2022 | 5,913 |
| Boniface John J. | Chief Scientific Officer | 04/26/2022 | 5,913 |
| Boniface John J. | Chief Scientific Officer | 04/19/2022 | 5,668 |
| Boniface John J. | Chief Scientific Officer | 04/12/2022 | 7,249 |
| Boniface John J. | Chief Scientific Officer | 04/06/2022 | 730 |
| Boniface John J. | Chief Scientific Officer | 04/05/2022 | 9,129 |
| Boniface John J. | Chief Scientific Officer | 04/06/2022 | 3,020 |
| Boniface John J. | Chief Scientific Officer | 03/29/2022 | 10,164 |
| Boniface John J. | Chief Scientific Officer | 03/22/2022 | 10,028 |
| Boniface John J. | Chief Scientific Officer | 03/14/2022 | 10,737 |
| Boniface John J. | Chief Scientific Officer | 03/11/2022 | 55,479 |
| Boniface John J. | Chief Scientific Officer | 12/06/2021 | 18,259 |
Load More Insider Transactions
FUNDS WITH A POSITION IN SERA PROGNOSTICS INC
| Fund | # Shares Owned | % of Portfolio | % Change | Investing Style |
|---|---|---|---|---|
| BAKER BROS. ADVISORS LP | 5,434,399 | 0.62% | No change | Other |
| RA CAPITAL MANAGEMENT, L.P. | 2,024,221 | 0.24% | New | Other |
| VIVO CAPITAL, LLC | 1,650,440 | 1.18% | No change | Other |
| GEODE CAPITAL MANAGEMENT, LLC | 207,778 | 0.00017% | 2.56% | Other |
| BLACKROCK INC. | 118,964 | 0.00003% | 35.25% | Other |
| BALYASNY ASSET MANAGEMENT L.P. | 19,959 | 0.00032% | New | Event Driven |
CHANGE IN SHARES OUTSTANDING FOR SERA PROGNOSTICS INC
STOCK BUYBACKS FOR SERA PROGNOSTICS INC
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
Load More
Period of Report: 12/31/2023
10-K/10-Q Filings: View
Previous Period
% Change in Shares
Quarter
09/30/2023
0.42%
1Q
06/30/2023
1.09%
2Q
03/31/2023
1.28%
3Q
12/31/2022
1.28%
4Q
09/30/2022
1.32%
5Q
06/30/2022
1.52%
6Q
03/31/2022
2.00%
7Q
09/30/2021
25.24%
9Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR SERA PROGNOSTICS INC
LOADING...